N. Arvind Dasari is a Professor and Director of Clinical Research at MD Anderson Cancer Center, specializing in gastrointestinal cancers. With a background from the University of Pittsburgh, he is a leader in clinical trials for neuroendocrine tumors and colorectal cancer, and serves as co-chair for national committees like the SWOG Neuroendocrine Subcommittee.
He was the lead investigator for the global FRESCO-2 Phase III trial, presenting findings that support a new, practice-changing treatment option for patients with refractory metastatic colorectal cancer.
Read the full overview →They do not like taking risks at all and go for proven options in the end. They are quite aware of their needs and limitations, so they are unlikely to over-promise. Being observant comes to them naturally.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.